Aeterna Zentaris Reports Second Quarter 2022 Financial
– Company ended the quarter with $58.2 million in cash – Driving continued progress across diversified pre-clinical and clinical development pipeline ...
Source: globenewswire.com
Stay updated with breaking news from Acimorelin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Company ended the quarter with $58.2 million in cash – Driving continued progress across diversified pre-clinical and clinical development pipeline ...
- Aeterna Zentaris granted exclusive option to negotiate a license of any resulting intellectual property and know-how developed by the University related...